A new method for maturity-dependent fractionation of neutrophil progenitors applicable for the study of myelodysplastic syndromes

Table 1 Clinical and hematological findings and treatment in six patients with MDS

Diagnosis	Age/sex	WBC (×10 ⁹/L)	ANC (×10 ⁹/L)	Hb (g/dL)	PLT (×10 ⁹/L)	BM NCC (×10 ⁹/L)	Karyotypes	Therapy
RCUD	74/M	4.5	3.5	8.4	206	143	46,XY	None
RCMD 1	66/M	2.4	1.7	9.2	46	37	46,XY	None
RCMD 2	79/F	3.5	2.0	10.3	6	50	46,XX	RBC and platelet transfusion
RCMD 3	73/M	2.8	1.4	10.3	79	207	46,XY,del(20)(q11)	None
RCMD 4	26/F	4.0	0.9	11.2	50	35	46,XX	None
RARS	83/M	4.8	3.4	6.1	336	240	46,XY	None

Abbreviations; WBC white blood cell counts, ANC absolute neutrophil counts, Hb concentration of hemoglobin, PLT platelet counts.
BM NCC bone marrow nucleated cell counts, M male, F female, RBC red blood cells, RCUD refractory cytopenia with unilineage dysplasia, RCMD refractory cytopenia with multilineage dysplasia, RARS refractory anemia with ringed sideroblasts.

ISSN: 2050-7771